Fosamax is a bisphosphonate and, more and more, research supports a link between atypical fractures of the femur, generally without trauma, and bisphosphonate use. The drugs are prescribed to improve bone density and minimize osteoporosis-related bone fracture. Just recently, two more victims who have used osteoporosis drug, Fosamax, have come forward and filed suits against the drug manufacturer.
Other oral bisphosphonates are Actonel, Boniva, Didronel, and Skelid. Intravenously administered bisphosphonates are Aredia, Bonefos, and Zometa, and are prescribed to prevent fractures due to bone metastases in cancer patients.
Atypical femur fractures can happen with no or very little impact to the thigh and can happen in both thighs in one patient. Signs of this type of fracture can include a dull, aching pain in the thigh, hip, or groin. A partial fracture can become a complete fracture in weeks or months. These fractures are very uncommon and only account for less than one percent of all hip and femur fractures.[related_posts limit=”5″]